New drug duo aims to shield fragile hearts after hip breaks
NCT ID NCT07228663
Summary
This study is testing if taking two common blood-thinning medications together for 90 days is better than the standard 30-day treatment at preventing heart attacks, strokes, and dangerous blood clots in patients who have just had hip fracture surgery and show signs of heart injury. It will involve 100 patients aged 45 and older. The main goal of this pilot study is to see if a larger, definitive trial is feasible by checking how many patients can be recruited and if they can stick to the treatment plan.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for VENOUS THROMBOEMBOLISM (VTE) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Humanitas Research Hospital
Milan, Italy
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Juravinski Hospital
Hamilton, Ontario, L8V 1C3, Canada
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
St.Joseph's Healthcare Hamilton
Hamilton, Ontario, L8N 4A6, Canada
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.